Protide News
Events
Looking forward to seeing you at future conferences.
Continue reading →
Protide Announces Distribution Agreement with VWR International LLC
Distribution Agreement with VWR International LLC Protide Pharmaceuticals, Inc. is pleased to announce we have completed a distribution agreement with VWR International LLC, an Avantor, Inc. company. Protide is excited to support VWR’s life science catalog with our Characterized Cell
Continue reading →
Protide Celebrates 35 Years
Protide Celebrates 35 Years Protide Pharmaceuticals, Inc. is excited to celebrate our 35th anniversary. Since our inception, Protide has been at the forefront of Characterized Cell Growth and cryopreservation technologies. Protide pioneered Characterized Cell Growth Solutions 35 years ago when
Continue reading →
Automated leukapheresis cryopreparation using Protide’s 2-8CELLsius
Automated leukapheresis cryopreparation using Protide’s 2-8CELLsius 2-8CELLsius™ and 2-8CELLsius™ + DMSO utilized in Fresenius Kabi study. Please click to read more on the Cytotherapy Journal website.
Continue reading →
2-8CELLsius™ alternative packaging options
2-8CELLsius™ alternative packaging Protide Pharmaceuticals, Inc. is excited to announce alternative packaging options for 2-8CELLsius™ (Cell washing/Short-term storage) and 2-8CELLsius™ + DMSO (Cryopreservation). Both products are now available in 1L media exchange bags for cellular processing devices. A DMF is
Continue reading →